ProCE Banner Activity

CME

Expert Perspectives on Managing Functional Bowel Disorders in Rural Settings

In this CME-certified video for primary care, experts discuss how to best communicate with patients to ensure proper diagnosis and optimal treatment strategies for IBS.

Physicians: maximum of 0.75 AMA PRA Category 1 CreditTM

Released: December 19, 2019

Expiration: December 18, 2020

No longer available for credit.

Share

Faculty

Lin Chang

Lin Chang, MD

Professor of Medicine
Vice-Chief
Vatche and Tamar Manoukian Division of Digestive Diseases
David Geffen School of Medicine at UCLA
Los Angeles, California

William D. Chey

William D. Chey, MD

Professor
University of Michigan Health System
Nostrant Collegiate Professor of Gastroenterology & Nutrition Sciences
Division of Gastroenterology
Michigan Medicine
Ann Arbor, Michigan

Provided by

Provided by the American Gastroenterology Association.
ProCE Banner

Supporters

Supported by an educational grant from

Salix Pharmaceuticals

Partners

NRHA

ProCE Banner

Target Audience

This program is intended for physicians, physician assistants, nurse practitioners, nurses, and other healthcare providers who care for patients with IBS or CIC.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Utilize Rome criteria to diagnose IBS-D and IBS-C and distinguish IBS-C from CIC
  • Consider evidence-based therapies for patients with IBS who have not responded to conventional dietary and pharmacologic interventions

Faculty Disclosure

Primary Author

Lin Chang, MD

Professor of Medicine
Vice-Chief
Vatche and Tamar Manoukian Division of Digestive Diseases
David Geffen School of Medicine at UCLA
Los Angeles, California

Lin Chang, MD, has disclosed that she has received consulting fees from Arena, Ironwood, OrphoMed, and Shire-Takeda; has received fees for non-CME/CE services from Allergen and Shire-Takeda; has received royalties from the Rome Foundation; and has less than 5% ownership interest in MetaMe Health and Modify Health.

William D. Chey, MD

Professor
University of Michigan Health System
Nostrant Collegiate Professor of Gastroenterology & Nutrition Sciences
Division of Gastroenterology
Michigan Medicine
Ann Arbor, Michigan

William D. Chey, MD, has disclosed that he has received consulting fees from Allergen, Biomerica, IM Health, Ironwood, Outpost, Phathom, Ritter, Redhill, Salix, and Urovant; holds intellectual property rights/patents from Digital Manometry, My Nutrition Health, and Rectal Expulsion Device; has received funds for research support from Biomerica, Ironwood, Nestle, Salix, Vibrant, Urovant, and Zespri; and has less than 5% ownership in Modify Health and Ritter.

Staff Disclosure

Staff

Tiffany Hensley-McBain, PhD

Clinical Editor

Tiffany Hensley-McBain, PhD, has no relevant conflicts of interest to report.

Kara Nyberg, PhD

Editorial Contributor

Kara Nyberg, PhD, has no relevant conflicts of interest to report.

Zachary Schwartz, MSc, ELS

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.

Carolyn Skowronski, PharmD

Associate Director, Scientific Services

Carolyn Skowronski, PharmD, has no relevant conflicts of interest to report.

Instructions for Credit

Accreditation Statement

American Gastroenterological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

American Gastroenterological Association designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 19, 2019, through December 18, 2020:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve rural clinicians’ competence in effectively communicating with patients about sensitive GI concerns; diagnosing IBS-C, IBS-D, and CIC; and developing evidence-based treatment regimens to alleviate symptoms.